D
The startup develops point-of-care diagnostics that utilize multi-marker testing for diabetes and tuberculosis, enabling healthcare professionals to conduct assessments and make clinical decisions at the time and location of patient care. Their products cover the entire diabetes care continuum, from initial evaluation to post-diagnosis treatment, improving patient management and outcomes.
Gunpo, South Korea
Updated 2 months ago
Funding
$3.6M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops point-of-care diagnostics that utilize multi-marker testing for diabetes and tuberculosis, enabling healthcare professionals to conduct assessments and make clinical decisions at the time and location of patient care. Their products cover the entire diabetes care continuum, from initial evaluation to post-diagnosis treatment, improving patient management and outcomes.